Table 4 Positive biopsy ratio for gastric cancer over 5 years
From: The optimal screening interval for gastric cancer using esophago-gastro-duodenoscopy in Japan
<40 | 40-49 | 50-59 | 60-69 | ≥70 | Total | |
|---|---|---|---|---|---|---|
2006 | 0 / 4 | 0 / 27 | 0 / 55 | 2 / 57 | 2 / 18 | 4 / 161 |
2007 | 0 / 9 | 1 / 32 | 3 / 76 | 2 / 62 | 1 / 34 | 7 / 213 |
2008 | 0 / 4 | 1 / 35 | 1 / 70 | 2 / 53 | 2 / 26 | 6 / 188 |
2009 | 0 / 4 | 1 / 18 | 2 / 64 | 4 /67 | 2 / 35 | 9 / 188 |
2010 | 0 / 6 | 0 /47 | 6 / 79 | 3 /50 | 0 / 32 | 9 / 214 |
Total (%) | 0 / 27 (0) | 3 / 159 (1.9) | 12 / 344 (3.5) | 13 / 289 (4.5) | 7 / 145 (4.8) | 35 / 964 (3.6) |